BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 34140928)

  • 1. Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus.
    Ramírez-Alarcón K; Victoriano M; Mardones L; Villagran M; Al-Harrasi A; Al-Rawahi A; Cruz-Martins N; Sharifi-Rad J; Martorell M
    Front Endocrinol (Lausanne); 2021; 12():656978. PubMed ID: 34140928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.
    Yang SC; Hsu CY; Chou WL; Fang JY; Chuang SY
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive alkaloidal and phenolic phytochemicals as promising epidrugs for diabetes mellitus 2: A review of recent development.
    Ayipo YO; Chong CF; Abdulameed HT; Mordi MN
    Fitoterapia; 2024 Jun; 175():105922. PubMed ID: 38552806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
    Hossan T; Kundu S; Alam SS; Nagarajan S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitus.
    Zhao C; Yang C; Wai STC; Zhang Y; P Portillo M; Paoli P; Wu Y; San Cheang W; Liu B; Carpéné C; Xiao J; Cao H
    Crit Rev Food Sci Nutr; 2019; 59(6):830-847. PubMed ID: 30501400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?
    Coco C; Sgarra L; Potenza MA; Nacci C; Pasculli B; Barbano R; Parrella P; Montagnani M
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytochemicals targeting genes relevant for type 2 diabetes.
    Anuradha CV
    Can J Physiol Pharmacol; 2013 Jun; 91(6):397-411. PubMed ID: 23745945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does epigenetic dysregulation of pancreatic islets contribute to impaired insulin secretion and type 2 diabetes?
    Dayeh T; Ling C
    Biochem Cell Biol; 2015 Oct; 93(5):511-21. PubMed ID: 26369706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network pharmacology of bioactives from Sorghum bicolor with targets related to diabetes mellitus.
    Oh KK; Adnan M; Cho DH
    PLoS One; 2020; 15(12):e0240873. PubMed ID: 33382706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate therapy for type 2 diabetes mellitus in view of pancreatic β-cell glucose toxicity: "the earlier, the better".
    Kaneto H; Matsuoka TA; Kimura T; Obata A; Shimoda M; Kamei S; Mune T; Kaku K
    J Diabetes; 2016 Mar; 8(2):183-9. PubMed ID: 26223490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise.
    Kong M; Xie K; Lv M; Li J; Yao J; Yan K; Wu X; Xu Y; Ye D
    Biomed Pharmacother; 2021 Jan; 133():110975. PubMed ID: 33212375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic memory and diabetic nephropathy: Beneficial effects of natural epigenetic modifiers.
    Kushwaha K; Sharma S; Gupta J
    Biochimie; 2020 Mar; 170():140-151. PubMed ID: 31954720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications.
    Tan D; Tseng HHL; Zhong Z; Wang S; Vong CT; Wang Y
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytochemicals and their Potential Mechanisms against Insulin Resistance.
    Wal P
    Curr Diabetes Rev; 2024; 20(7):e081123223322. PubMed ID: 37946350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade.
    Xu Q; Wang L; Luo J; Shi D
    Curr Drug Targets; 2018; 19(1):55-69. PubMed ID: 28270085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a Target.
    Gothai S; Ganesan P; Park SY; Fakurazi S; Choi DK; Arulselvan P
    Nutrients; 2016 Aug; 8(8):. PubMed ID: 27527213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in diabetes and the regulatory roles of antidiabetic agents on the mitochondrial function.
    Yaribeygi H; Atkin SL; Sahebkar A
    J Cell Physiol; 2019 Jun; 234(6):8402-8410. PubMed ID: 30417488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Szoke E; Gerich JE
    Compr Ther; 2005; 31(2):106-12. PubMed ID: 15901939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of 'Diabesity': Beyond Pharmacotherapy.
    Singh H; Venkatesan V
    Curr Drug Targets; 2018; 19(14):1672-1682. PubMed ID: 29929463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.